NASDAQ NMS - GLOBAL MARKET · HYPR
0.00% · $0.0000 · Vol 185.4K
Market closed · last close 4:00 PM ET · price as of 18:24:09 ET
Hyperfine Inc

Hyperfine Inc

Health Care
$0.7900
Card
Relationship Map

Follow $HYPR

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $HYPR by email

Veridion Score

BETALOW CONF · 4 of 6 factors measuredMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
HYPR
Hyperfine Inc
Thu Sep 24 · market closed · Markets closed · resumes Fri 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

48/ 100
Veridion Score
Middle range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: LOW · 4 of 6 factors measured · Thu Sep 24 · market closed · Markets closed · resumes Fri 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is HYPR moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading HYPR catalysts
About Hyperfine Inc
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Listed since
2021
Employees
102
Country
US

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.7900
Day high
$0.8044
Day low
$0.7700
Previous close
$0.7900
52W high
$2.20
-64.09% from high
52W low
$0.7700
1% of range
Market cap
$83.8M
EPS
$-0.4400
Beta
1.89
Shares out
106M
Volume
185.4K
0.39× rel vol
Avg volume
471.9K
VWAP
$0.7871
Price history computed in-house
1W
+0.68%
1M
-9.00%
3M
-46.26%
1Y
-45.89%
YTD
-19.33%
SMA 50 $0.8817 · below
SMA 200 $1.16 · below
52W position 1%

HYPR overview

Loading financial statements
Loading HYPR Form 4 filings
Public disclosures

Congress activity in HYPR

No receipt-qualified Congressional disclosure is present for HYPR in the cached public ledger.

Federal contracts

HYPR contract awards, year to date.

Public federal awards linked to this ticker.

$242.5K
Refresh interval: 12hSource: Federal contract awards
Department of Health and Human Services
$242.5K
HYPERFINE PORTABLE MR IMAGING SYSTEM V2. CLINICAL SUPPORT ON SITE IMPLEMENTATION, HYPERFINE CUSTOMER ON-SITE TRAINING, FIRST YEAR LIMITED WARRANTY, SOFTWARE UPDATES, SERVICE, AND SUPPORT (YEARS 2-5). REFERENCE QUOTE 2277/2026.

HYPERFINE PORTABLE MR IMAGING SYSTEM V2. CLINICAL SUPPORT ON SITE IMPLEMENTATION, HY...

Jun 10, 2026
Lobbying spend

HYPR lobbying filings, year to date.

Registered lobbying filings matched to Hyperfine Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for HYPR in this window.
Loading news for HYPR
Analyst ratings
Sovereign unlock shows live analyst consensus for HYPR.
Options
Sovereign unlock shows live options positioning for HYPR.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.